Introduction to Risk Assessment
Toxicological risk assessments are prepared to provide a thorough review of the chemicals in your extractables/leachables report. Following ISO 10993 - 17, our toxicologists assess each chemical to establish a margin of safety and determine whether the further testing or analysis is required to reduce the risk.
Toxicological risk assessment 
Biological evaluation 
R&D Design Discussion 
Problem solving 
Other 
It represents a substance-specific dose that is unlikely to cause an adverse effect if an individual is exposed at or below this dose every day for a lifetime.
Following the relevant guidelines, experienced toxicologists will use high-quality data and identify the sensitive toxicity endpoint (such as NOAEL, LOAEL, etc.) based on existing information, registered materials or other officially released safety limits, and apply the appropriate uncertainty factor (UF1-UFn) to evaluate the PDE. When necessary, use computer toxicity prediction software (QSAR method) to predict the toxicity.
- ICH Q3C. Impurity: guideline for residual solvents Q3C
- ICH Q3D. Guideline for elemental impurities Q3D
- ISO 10993-17. Biological evaluation of medical devices -- Part 17: Toxicological risk assessment of medical device constituents. 2023
- EMA/CHMP/ CVMP/ SWP/169430/2012. Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities
- Published literatures for “Setting Occupational Exposure Limits (OELs) for Pharmaceuticals”
- Global certified experienced toxicologist team
- More than 38,000 items of toxicological assessment data for chemical substances
- Standard reporting templates for global submissions
- Internationally recognized toxicity prediction software(QSAR)
- Safety Assessment of Pharmaceutical Packaging
- Residue Limits Setting in Pharmaceutical Manufacturing Environments